The fetal-to-adult hemoglobin switching at about the time of birth involves a shift in expression from γ-globin to β-globin in erythroid cells. Effective re-expression of fetal γ-globin can ameliorate sickle cell anemia and β-thalassemia. Despite the physiological and clinical relevance of this switch, its posttranscriptional regulation is poorly understood. Here, we identify Pumilo 1 (PUM1), an RNA-binding protein with no previously reported functions in erythropoiesis, as a direct posttranscriptional regulator of β-globin switching. PUM1, whose expression is regulated by the erythroid master transcription factor erythroid Krüppel-like factor (EKLF/KLF1), peaks during erythroid differentiation, binds γ-globin messenger RNA (mRNA), and reduces γ-globin (HBG1) mRNA stability and translational efficiency, which culminates in reduced γ-globin protein levels. Knockdown of PUM1 leads to a robust increase in fetal hemoglobin (∼22% HbF) without affecting β-globin levels in human erythroid cells. Importantly, targeting PUM1 does not limit the progression of erythropoiesis, which provides a potentially safe and effective treatment strategy for sickle cell anemia and β-thalassemia. In support of this idea, we report elevated levels of HbF in the absence of anemia in an individual with a novel heterozygous PUM1 mutation in the RNA-binding domain (p.(His1090Profs∗16); c.3267_3270delTCAC), which suggests that PUM1-mediated posttranscriptional regulation is a critical player during human hemoglobin switching.
1 July 2017 in International Journal of Biological Macromolecules
Krüppel-like factor 1 [KLF1; also known as erythroid Krüppel-like factor (EKLF)] is a C2H2 zinc finger transcription factor that plays a crucial role in all aspects of erythropoiesis. Mutations in KLF1 lead to diverse phenotypes ranging from mild to severe anemias. Individuals with a heterozygous E325K mutation [congenital dyserythropoietic anemia (CDA) type IV] exhibit impaired erythroid terminal differentiation and increased presence of binucleate erythroblasts. We have previously shown that KLF1 is necessary for cell cycle exit and enucleation in mouse primary cells. In the present study, we discovered that genes involved in cell motility, cell division and mitotic pathways are all directly regulated by KLF1. Klf1−/− cells exhibit increased numbers of binucleated erythroblasts and DNA bridges, and differentiating Klf1−/− erythroblasts display an increased percentage of cytokinesis failure events and defective microtubule bundling. Klf1−/− erythroblasts produce frequent aberrant F-actin-rich membrane protrusions and anucleate cell fragments. Human CDA type IV cells exhibit similar patterns of dysregulation of cytokinesis and cell motility genes. Collectively, we show that KLF1 is necessary for maintaining the integrity of erythroid cell divisions by direct regulation of genes involved in cytokinesis and motility pathways during terminal erythroid differentiation.